Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity
- PMID: 21920712
- PMCID: PMC3185127
- DOI: 10.1016/j.pscychresns.2011.06.014
Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity
Abstract
Despite numerous studies on the role of medial temporal lobe structures in Alzheimer's disease (AD), the magnitude and clinical significance of amygdala atrophy have been relatively sparsely investigated. In this study, we used magnetic resonance imaging (MRI) to compare the level of amygdala atrophy to that of the hippocampus in very mild and mild AD subjects in two large samples (Sample 1 n=90; Sample 2 n=174). Using a series of linear regression analyses, we investigated whether amygdala atrophy is related to global cognitive functioning (Clinical Dementia Rating Sum of Boxes: CDR-SB; Mini Mental State Examination: MMSE) and neuropsychiatric status. Results indicated that amygdala atrophy was comparable to hippocampal atrophy in both samples. MMSE and CDR-SB were strongly related to amygdala atrophy, with amygdala atrophy predicting MMSE scores as well as hippocampal atrophy, but predicting CDR-SB scores less robustly. Amygdala atrophy was related to aberrant motor behavior, with potential relationships to anxiety and irritability. These results suggest that the magnitude of amygdala atrophy is comparable to that of the hippocampus in the earliest clinical stages of AD, and is related to global illness severity. There also appear to be specific relationships between the level of amygdala atrophy and neuropsychiatric symptoms that deserve further investigation.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Figures
Similar articles
-
High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment.Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):139-45. doi: 10.1097/WAD.0b013e318192e745. Alzheimer Dis Assoc Disord. 2009. PMID: 19474571 Free PMC article.
-
The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.Hum Brain Mapp. 2015 Jun;36(6):2093-117. doi: 10.1002/hbm.22758. Epub 2015 Feb 3. Hum Brain Mapp. 2015. PMID: 25644981 Free PMC article.
-
Five-year retrospective changes in hippocampal atrophy and cognitive screening test performances in very mild Alzheimer's disease: the Tajiri Project.Neuroradiology. 2002 Jan;44(1):43-8. doi: 10.1007/s002340100688. Neuroradiology. 2002. PMID: 11942499
-
Magnetic resonance analysis of amygdalar volume in Alzheimer's disease.Curr Opin Psychiatry. 2007 May;20(3):273-7. doi: 10.1097/YCO.0b013e3280ebb613. Curr Opin Psychiatry. 2007. PMID: 17415082 Review.
-
Amygdala activity and amygdala-hippocampus connectivity: Metabolic diseases, dementia, and neuropsychiatric issues.Biomed Pharmacother. 2023 Jun;162:114647. doi: 10.1016/j.biopha.2023.114647. Epub 2023 Apr 1. Biomed Pharmacother. 2023. PMID: 37011482 Review.
Cited by
-
Knockdown of microglial iron import gene, Slc11a2, worsens cognitive function and alters microglial transcriptional landscape in a sex-specific manner in the APP/PS1 model of Alzheimer's disease.J Neuroinflammation. 2024 Sep 27;21(1):238. doi: 10.1186/s12974-024-03238-w. J Neuroinflammation. 2024. PMID: 39334471 Free PMC article.
-
Genetics-driven risk predictions leveraging the Mendelian randomization framework.Genome Res. 2024 Oct 11;34(9):1276-1285. doi: 10.1101/gr.279252.124. Genome Res. 2024. PMID: 39332904 Free PMC article.
-
MRI evidence of gray matter loss in COVID-19 patients with cognitive and olfactory disorders.Ann Clin Transl Neurol. 2024 Sep;11(9):2457-2472. doi: 10.1002/acn3.52164. Epub 2024 Jul 30. Ann Clin Transl Neurol. 2024. PMID: 39080851 Free PMC article.
-
Amygdala and cognitive impairment in cerebral small vessel disease: structural, functional, and metabolic changes.Front Neurol. 2024 Jul 12;15:1398009. doi: 10.3389/fneur.2024.1398009. eCollection 2024. Front Neurol. 2024. PMID: 39070051 Free PMC article. Review.
-
Patterns of longitudinal subcortical atrophy over one year in amnestic mild cognitive impairment and its impact on cognitive performance: a preliminary study.Turk J Med Sci. 2024 Mar 11;54(3):588-597. doi: 10.55730/1300-0144.5826. eCollection 2024. Turk J Med Sci. 2024. PMID: 39049994 Free PMC article.
References
-
- Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 1992;42:631–9. - PubMed
-
- Barnes J, Whitwell JL, Frost C, Josephs KA, Rossor M, Fox NC. Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Archives of Neurology. 2006;63:1434–9. - PubMed
-
- Basso M, Yang J, Warren L, MacAvoy MG, Varma P, Bronen RA, van Dyck CH. Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease. Psychiatry Research. 2006;146:251–61. - PubMed
Publication types
MeSH terms
Grants and funding
- DP10D003312/DP/NCCDPHP CDC HHS/United States
- P50-AG05134/AG/NIA NIH HHS/United States
- P01 AG003991-29/AG/NIA NIH HHS/United States
- U24 RR021382-05/RR/NCRR NIH HHS/United States
- R01-AG029411/AG/NIA NIH HHS/United States
- P01-AG003991/AG/NIA NIH HHS/United States
- R21-AG029840/AG/NIA NIH HHS/United States
- R01-MH56584/MH/NIMH NIH HHS/United States
- P50-AG05681/AG/NIA NIH HHS/United States
- R21 AG029840/AG/NIA NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- R01 AG030311/AG/NIA NIH HHS/United States
- K01 AG030514/AG/NIA NIH HHS/United States
- U24 RR021382/RR/NCRR NIH HHS/United States
- R01 AG029411/AG/NIA NIH HHS/United States
- R01 MH056584/MH/NIMH NIH HHS/United States
- P30 AG062421/AG/NIA NIH HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- U19 AG010483/AG/NIA NIH HHS/United States
- P01 AG003991/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- R01 AG029411-05/AG/NIA NIH HHS/United States
- R21 AG029840-02/AG/NIA NIH HHS/United States
- P50 AG005134/AG/NIA NIH HHS/United States
- DP1 OD003312/OD/NIH HHS/United States
- P50 AG005681-29/AG/NIA NIH HHS/United States
- U24-RR021382/RR/NCRR NIH HHS/United States
- R01-AG030311/AG/NIA NIH HHS/United States
- P50 AG005134-29/AG/NIA NIH HHS/United States
- U01 AG024904-07/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical